We are live on ! Find out more
IRD

Opus Genetics
IRD

37 hedge funds and large institutions have $5.69M invested in Opus Genetics in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more capital invested

Capital invested by funds: $4.62M → $5.69M (+$1.06M)

1.3% more ownership

Funds ownership: 12.44% → 13.73% (+1.3%)

0% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 6

3% less funds holding

Funds holding: 38 → 37 (-1)

22% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 9

Holders
37
Holders Change
-1
Holders Change %
-2.63%
% of All Funds
0.64%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
7
Reduced
9
Closed
6
Calls
$690K
Puts
–
Net Calls
+$690K
Net Calls Change
-$74K

Top Buyers

Rank Fund Capital Flow
1
MCM
MAI Capital Management
Ohio
+$770K
2
RHJA
Rice Hall James & Associates
California
+$459K
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$55.2K
4
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors
North Carolina
+$38.8K
5
JP Morgan Chase
JP Morgan Chase
New York
+$33.7K

Top Sellers

Rank Fund Capital Flow
1
Two Sigma Advisers
Two Sigma Advisers
New York
-$290K
2
Citadel Advisors
Citadel Advisors
Florida
-$35.5K
3
PCM
Prelude Capital Management
New York
-$34K
4
Millennium Management
Millennium Management
New York
-$24K
5
DC
Diametric Capital
Massachusetts
-$21.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.41M – – –
RHJA
2
Rice Hall James & Associates
California
$1.09M +$459K +212,854 +65%
MCM
3
MAI Capital Management
Ohio
$717K +$770K +356,948 New
RB
4
Richmond Brothers
Michigan
$641K +$19.9K +9,212 +3%
Renaissance Technologies
5
Renaissance Technologies
New York
$416K +$18.8K +8,711 +4%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$304K +$8.87K +4,110 +3%
BlackRock
7
BlackRock
New York
$135K -$9.6K -4,452 -6%
State Street
8
State Street
Massachusetts
$125K – – –
Susquehanna International Group
9
Susquehanna International Group
Pennsylvania
$74K -$17.3K -8,040 -18%
Comerica Bank
10
Comerica Bank
Texas
$68K – – –
Morgan Stanley
11
Morgan Stanley
New York
$66K -$4.45K -2,063 -6%
Ameriprise
12
Ameriprise
Minnesota
$60K – – –
EVC
13
Eidelman Virant Capital
Missouri
$51K – – –
Dimensional Fund Advisors
14
Dimensional Fund Advisors
Texas
$51K +$55.2K +25,576 New
Millennium Management
15
Millennium Management
New York
$49K -$24K -11,119 -31%
DC
16
Diametric Capital
Massachusetts
$49K -$21.2K -9,808 -29%
Northern Trust
17
Northern Trust
Illinois
$45K – – –
WAM
18
Warberg Asset Management
Illinois
$42K -$6.9K -3,200 -13%
CAPTRUST Financial Advisors
19
CAPTRUST Financial Advisors
North Carolina
$39K +$38.8K +18,001 +1,200%
Two Sigma Advisers
20
Two Sigma Advisers
New York
$37K -$290K -134,200 -88%
Charles Schwab
21
Charles Schwab
California
$31K – – –
BFC
22
Bedel Financial Consulting
Indiana
$31K +$32.4K +15,000 New
JP Morgan Chase
23
JP Morgan Chase
New York
$31K +$33.7K +15,600 New
SFI
24
Susquehanna Fundamental Investments
Pennsylvania
$30K +$32.6K +15,105 New
CC
25
Cornerstone Capital
California
$28K – – –
1
2

IRD Hedge Fund Activity: Q3 2022 in Review

37 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Opus Genetics (IRD) for Q3 2022, worth a combined $5.69M — up 23% from $4.62M a quarter earlier.

Fund positioning in IRD was balanced in Q3 2022: 6 funds opened new positions, 6 closed out, 7 added to existing stakes and 9 trimmed.

The largest buyer was MAI Capital Management, opening a new position worth an estimated $770K. The largest seller was Two Sigma Advisers, cutting an estimated $290K.

  • 37 institutional investors held Opus Genetics (IRD) as of Q3 2022, down from 38 in Q2 2022.
  • Funds reported $5.69M of Opus Genetics stock for Q3 2022, up 23% quarter-over-quarter.
  • 6 funds opened new Opus Genetics positions in Q3 2022 and 6 closed out, a net change of 0 holders.
  • The largest Opus Genetics buyer in Q3 2022 was MAI Capital Management, an estimated $770K added.
  • The largest Opus Genetics seller in Q3 2022 was Two Sigma Advisers, an estimated $290K sold.

Based on aggregated 13F filings for Q3 2022.